Literature DB >> 32065550

Flow cytometry evaluation of infection-related biomarkers in febrile subjects in the emergency department.

Pénélope Bourgoin1,2, Guillaume Lediagon3, Isabelle Arnoux4, Denis Bernot4, Pierre-Emmanuel Morange2,4, Pierre Michelet3, Fabrice Malergue1, Thibaut Markarian3.   

Abstract

Aim: In an Emergency Department (ED), the etiological identification of infected subjects is essential. 13 infection-related biomarkers were assessed using a new flow cytometry procedure. Materials & methods: If subjects presented with febrile symptoms at the ED, 13 biomarkers' levels, including CD64 on neutrophils (nCD64) and CD169 on monocytes (mCD169), were tested and compared with clinical records.
Results: Among 50 subjects, 78% had bacterial infections and 8% had viral infections. nCD64 showed 82% sensitivity and 91% specificity for identifying subjects with bacterial infections. mCD169, HLA-ABC ratio and HLA-DR on monocytes had high values in subjects with viral infections.
Conclusion: Biomarkers showed promising performances to improve the ED's infectious stratification.

Entities:  

Keywords:  bacterial infection; emergency department; fever; flow cytometry; viral infection

Mesh:

Substances:

Year:  2020        PMID: 32065550     DOI: 10.2217/fmb-2019-0256

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  7 in total

1.  One-step White Blood Cell Extracellular Staining Method for Flow Cytometry.

Authors:  Ines Ait Belkacem; Pénélope Bourgoin; Jean Marc Busnel; Franck Galland; Fabrice Malergue
Journal:  Bio Protoc       Date:  2021-08-20

2.  Monocyte CD169 expression in COVID-19 patients upon intensive care unit admission.

Authors:  Marine Ortillon; Remy Coudereau; Martin Cour; Thomas Rimmelé; Marine Godignon; Morgane Gossez; Hodane Yonis; Laurent Argaud; Anne-Claire Lukaszewicz; Fabienne Venet; Guillaume Monneret
Journal:  Cytometry A       Date:  2021-02-05       Impact factor: 4.714

3.  Validation of a Quick Flow Cytometry-Based Assay for Acute Infection Based on CD64 and CD169 Expression. New Tools for Early Diagnosis in COVID-19 Pandemic.

Authors:  Alejandra Comins-Boo; Maria Gutiérrez-Larrañaga; Adriel Roa-Bautista; Sandra Guiral Foz; Mónica Renuncio García; Elena González López; Juan Irure Ventura; María Carmen Fariñas-Álvarez; David San Segundo; Marcos López Hoyos
Journal:  Front Med (Lausanne)       Date:  2021-03-23

4.  CD169 and CD64 could help differentiate bacterial from CoVID-19 or other viral infections in the Emergency Department.

Authors:  Pénélope Bourgoin; Thomas Soliveres; Alexandra Barbaresi; Anderson Loundou; Inès Ait Belkacem; Isabelle Arnoux; Denis Bernot; Marie Loosveld; Pierre-Emmanuel Morange; Pierre Michelet; Fabrice Malergue; Thibaut Markarian
Journal:  Cytometry A       Date:  2021-02-08       Impact factor: 4.714

5.  A rapid, easy, and scalable whole blood monocyte CD169 assay for outpatient screening during SARS-CoV-2 outbreak, and potentially other emerging disease outbreaks.

Authors:  Moïse Michel; Fabrice Malergue; Inès Ait Belkacem; Pénélope Bourgoin; Pierre-Emmanuel Morange; Isabelle Arnoux; Tewfik Miloud; Matthieu Million; Hervé Tissot-Dupont; Jean-Louis Mege; Joana Vitte; Jean-Marc Busnel
Journal:  SAGE Open Med       Date:  2022-08-03

Review 6.  Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease.

Authors:  Silva Herzog; Paraskevi C Fragkou; Borros M Arneth; Samr Mkhlof; Chrysanthi Skevaki
Journal:  Front Med (Lausanne)       Date:  2022-09-23

Review 7.  Future Biomarkers for Infection and Inflammation in Febrile Children.

Authors:  Judith Zandstra; Ilse Jongerius; Taco W Kuijpers
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.